StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New documents out on Sedar- Nov 8

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Nov 08, 2021 10:55am

91 Views

Post# 34099728

RE:RE:RE:New documents out on Sedar- Nov 8

We should have been told what the milestones are, is it number of tests reached, revenue reached, or just that the original deal closed? I would really like to know this.

LithLover wrote: It's based on achieveing milestones that were agreed upon when the SP was over $1.00

Nice try. Showing your true colors again.

Liked2Think wrote: 8M more shares while always known to be happening will do just wonders for that SP

wonder what the PP price is going to be